Calporta Therapeutics
Latest round
- Series A
Last raised
- Jun 2015
Total raised
- $3M
Investors
- 2
About Calporta Therapeutics
Founded in 2015 and based in California, US, Calporta Therapeutics, Inc. operates as a developer of small molecule agonists of TRPML1 for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases.
Who invested in Calporta Therapeutics
2 investors across 1 round
See all investors in Calporta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 15, 2015
Amount
$3M
Investors
Questions about Calporta Therapeutics
Who invested in Calporta Therapeutics?
Calporta Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Calporta Therapeutics raised?
Calporta Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Calporta Therapeutics last raise money?
Calporta Therapeutics's most recent round on record is a Series A, in Jun 2015.
What does Calporta Therapeutics do?
Founded in 2015 and based in California, US, Calporta Therapeutics, Inc.
Where is Calporta Therapeutics headquartered?
Calporta Therapeutics is headquartered in US.
Which VCs invest in companies like Calporta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Calporta Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Calporta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.